Development and evaluation of a decision aid for patients considering first‐line chemotherapy for metastatic breast cancer

Objective  Treatment decisions in advanced breast cancer are complex, with enhanced quality of life and survival among important treatment goals. Patients with metastatic breast cancer face the decision of whether or not to have chemotherapy, and many wish to be involved in this decision. We report the development and evaluation of a decision aid (DA) designed to assist patients facing this treatment decision.

[1]  P Tugwell,et al.  A decision aid for women considering hormone therapy after menopause: decision support framework and evaluation. , 1998, Patient education and counseling.

[2]  Peter Watson,et al.  Do patients benefit from participating in medical decision making? Longitudinal follow‐up of women with breast cancer , 2006, Psycho-oncology.

[3]  C. Rose,et al.  The influence of chemotherapy on survival after recurrence in breast cancer--a population-based study of patients treated in the 1950s, 1960s and 1970s. , 1993, European journal of cancer.

[4]  P. Jönsson,et al.  A Systematic Overview of Chemotherapy Effects in Breast Cancer , 2001 .

[5]  R. Owens,et al.  Taking responsibility for cancer treatment. , 2001, Social science & medicine.

[6]  D. Streiner,et al.  Patients' preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument. , 1996, Gynecologic oncology.

[7]  I D Graham,et al.  The Ottawa patient decision aids. , 1999, Effective clinical practice : ECP.

[8]  P. Butow,et al.  Treatment decision aids in advanced cancer: when the goal is not cure and the answer is not clear. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  A Coulter.  Patient-centered decision making: empowering women to make informed choices. , 2001, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[10]  P. Schellhammer,et al.  Patients' choice of treatment in stage D prostate cancer. , 1989, Urology.

[11]  Amiram Gafni,et al.  Helping patients make informed choices: a randomized trial of a decision aid for adjuvant chemotherapy in lymph node-negative breast cancer. , 2003, Journal of the National Cancer Institute.

[12]  S. Ebbs,et al.  Does chemotherapy improve survival in advanced breast cancer? A statistical overview. , 1988, British Journal of Cancer.

[13]  M. Héry,et al.  [Node negative breast cancers: the good and the bad cases]. , 1990, Pathologie et biologie.

[14]  R. Gelber,et al.  Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  P Maguire,et al.  Psychological effects of being offered choice of surgery for breast cancer , 1994, BMJ.

[16]  A Coulter,et al.  Sharing decisions with patients: is the information good enough? , 1999, BMJ.

[17]  J. Bergh,et al.  A systematic overview of chemotherapy effects in breast cancer. , 2001, Acta oncologica.

[18]  Phyllis N Butow,et al.  When the treatment goal is not cure: are cancer patients equipped to make informed decisions? , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  T. Whelan,et al.  Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancer. , 1999, Patient education and counseling.

[20]  R. Carlson,et al.  Goals and objectives in the management of metastatic breast cancer. , 2003, The oncologist.

[21]  Barbara Gandek,et al.  Characteristics of Physicians with Participatory Decision-Making Styles , 1996, Annals of Internal Medicine.

[22]  K A Harris,et al.  The informational needs of patients with cancer and their families. , 1998, Cancer practice.

[23]  M. Stockler,et al.  Chemotherapy for metastatic breast cancer--when is enough enough? , 1997, European journal of cancer.

[24]  P M Bossuyt,et al.  Decision support for patients with early-stage breast cancer: effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  A. O'Connor.  Validation of a Decisional Conflict Scale , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.

[26]  J A Sloan,et al.  The Control Preferences Scale. , 1997, The Canadian journal of nursing research = Revue canadienne de recherche en sciences infirmieres.

[27]  M A Richards,et al.  Node negative breast cancer. , 1990, BMJ.

[28]  E. Cook,et al.  Relationship between cancer patients' predictions of prognosis and their treatment preferences. , 1998, JAMA.

[29]  D Feldman-Stewart,et al.  Phase I study of a decision aid for patients with locally advanced non-small-cell lung cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  P. Butow,et al.  Misunderstanding in cancer patients: why shoot the messenger? , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[31]  Ian Graham,et al.  Development and evaluation of a decision aid for patients with stage IV non‐small cell lung cancer , 2000, Health expectations : an international journal of public participation in health care and health policy.